![Doo-Hyun Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 134 233 $ in data 31/07/2026
Doo-Hyun Lee has been the Chief Executive Officer & Director at Vivozon, Inc. since 2008.
Since 2020, Dr. Lee has also been associated with Vivozon Pharmaceutical Co., Ltd., taking on the role of Director starting in 2023.
Dr. Lee holds a doctorate degree from Korea University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/07/2026 | 81.610 ( 0,13% ) | 134 233 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VIVOZON PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 20/01/2020 |
Vivozon, Inc.
 Vivozon, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Amministratore Delegato | 05/06/2008 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Vivozon Pharmaceutical Co., Ltd.
 Vivozon Pharmaceutical Co., Ltd. SemiconductorsElectronic Technology Manufactures and sells compound semiconductors | Electronic Technology |
Korea University
 Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivozon, Inc.
Vivozon, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
